Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Editorial Open access Oct 2026

Editorial: Mechanisms of drug resistance in cancer: overcoming barriers with novel pharmacological strategies

the importance of clinicopathological characterization and biomarker discovery. Emerging pharmacological approaches, including EZH2 inhibition, PARP-directed combination therapies, and natural product-based therapies such as (+)-PTC, may restore therapeutic sensitivity and ultimately contribute to precision oncology an...

Pulak Kar, D. Colangelo, M. Kumar et al. · 0 citations
Review Open access Sep 2026

Beyond angiogenesis: the paradoxical emerging pro-tumorigenic role of Thrombospondin-2

The tumor microenvironment is a complex ecosystem where the extracellular matrix serves as a dynamic signaling hub and regulates tumorigenesis. Thrombospondin-2 (THBS2), a matricellular extracellular matrix protein, has traditionally been regarded as an inhibitor of angiogenesis. However, emerging evidence reveals a pl...

Hetal Abhay Shah, M. Kumar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.